Diagnostic workup for diffuse parenchymal lung disease: Schematic flowchart, literature review, and pitfalls

Lung

Volumn 191, Issue 1, 2013, Pages 19-25

  Deconinck, Barbara ^a   Verschakelen, Johny ^a   Coolen, Johan ^a   Verbeken, Eric ^a   Verleden, Geert ^a   Wuyts, Wim ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Diagnosis; Diffuse parenchymal lung diseases; Interstitial lung diseases; Investigation; Pulmonary fibrosis

Indexed keywords

ANTINUCLEAR ANTIBODY; DIPEPTIDYL CARBOXYPEPTIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ARTERIAL GAS; BLOOD GAS ANALYSIS; BRONCHOSCOPY; CARDIOPULMONARY EXERCISE TEST; CLINICAL EXAMINATION; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DIFFUSE PARENCHYMAL LUNG DISEASE; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ERYTHROCYTE SEDIMENTATION RATE; HERPES SIMPLEX VIRUS; HISTOLOGY; HUMAN; IMMUNOCOMPROMISED PATIENT; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; KIDNEY FUNCTION TEST; LEUKOCYTE DIFFERENTIAL COUNT; LIVER FUNCTION TEST; LUNG DISEASE; LUNG FUNCTION TEST; LUNG LAVAGE; MEDICAL HISTORY; PH MEASUREMENT; PHYSICAL EXAMINATION; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; REVIEW; SENSITIVITY AND SPECIFICITY; THORACOTOMY; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; TRANSTHORACIC ECHOCARDIOGRAPHY; TUBERCULIN TEST; URINALYSIS; VIDEO ASSISTED THORACOSCOPIC SURGERY;

BIOPSY; BRONCHOSCOPY; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, RESPIRATORY SYSTEM; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; RESPIRATORY FUNCTION TESTS; SOFTWARE DESIGN;

EID: 84873083837     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-012-9433-5     Document Type: Review

References (52)

1. Ryu JH, Daniels GE, Hartman TE, Yi ES (2007) Diagnosis of interstitial lung diseases. Mayo Clin Proc 82(8):976-986
2. Fenoglio CM, Reboux G, Sudre B, Mercier M, Roussel S, Cordier JF et al (2007) Diagnostic value of serum precipitins to mould antigens in active hypersensitivity pneumonitis. Eur Respir J 29:706-712
3. Crystal RG, Gadek J, Ferrans V (1981) Interstitial lung disease: current concept of pathogenesis, staging and therapy. Am J Med 70:542-568
4. American Thoracic Society/European Respiratory Society (2002) International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165:277-304
5. Gomez AD, King TE (2007) Classification of diffuse parenchymal lung disease. In: Costable U, Dubois RM, Egan JJ (eds) Diffuse parenchymal lung disease, 1st edn. Karger AG, Basel, pp 2-10
6. Dempsey OJ, Kerr KM, Remmen H, Denison AR (2010) How to investigate a patient with suspected interstitial lung disease. BMJ 340:c2843
7. Clements PJ, Goldin JG, Keerup EC, Furst DE, Elashoff RM, Tashkin DP et al (2004) Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosis. Arthritis Rheum 50(6):1909-1917
8. Wells A, Hirani N (2008) On behalf of the British Thoracic Society Interstitial Lung Disease Guideline Group, a subgroup of the British Thoracic Society Standards of Care Committee, in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Interstitial lung disease guidelines: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 63:v1-v58
9. Foulon G, Delaval P, Valeyre D, Wallaert B, Debray MP, Brauner M et al (2008) ANCA-associated lung fibrosis: analysis of 17 patients. Respir Med 102:1392-1398
10. Nozu T, Kondo M, Suzuki K, Tamaoki J, Nagai A (2009) A comparison of the clinical features of ANCA-positive and ANCA-negative idiopathic pulmonary fibrosis patients. Respiration 77:407-415
11. Inui N, Enomoto N, Suda T, Kageyama Y, Watanabe H, Chida K (2008) Anti-cyclic citrullinated peptide antibodies in lung disease associated with rheumatoid arthritis. Clin Biochem 41:1074-1077
12. Mittoo S, Gelber AC, Christopher-Stine L, Horton MR, Lechtzin N, Danoff SK (2009) Ascertainment of collagen vascular disease in patients presenting with interstitial lung disease. Respir Med 103:1152-1158
13. Fischer A, du Bois R (2012) Interstitial lung disease in connective tissue disorders. Lancet 380:689-698
14. Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM (2010) Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest 138(2):251-256
15. Vij R, Noth I, Strek ME (2011) Autoimmune-featured interstitial lung disease: a distinct entity. Chest 140(5):1292-1299
16. Newman LS, Rose CS, Maier LA (1997) Sarcoidosis. N Engl J Med 336:1224-1234
17. Baudin B (2005) L'enzyme de conversion de l'angiotensine I (ECA) dans le diagnostic de la sarcoïdose. Pathol Biol 53:183-188
18. Kruit A, Grutters JC, Cerritsen WB, Kos S, Wodzig WK, van den Bosch JM et al (2007) ACE I/D-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis. Respir Med 101:510-515
19. Lacasse Y, Selman M, Costabel U, Dalphin JC, Ando M, Morell F et al (2003) Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med 168:952-958
20. Ilavská S, Jahnová E, Tulinská J, Horvátohová M, Dusinská M, Wsolová L et al (2005) Immunological monitoring in workers occupationally exposed to asbestos. Toxicology 206:299-308
21. Ueda T, Ohta K, Suzuki N, Yamaguchi M, Hirai K, Horiuchi T et al (1992) Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am Rev Respir Dis 146:266-268
22. Moorman J, Saad M, Kosseifi S, Krishnaswamy G (2005) Hepatitis C virus and the lung: implications for therapy. Chest 128:2882-2892
23. Arase Y, Suzuki F, Suzuki Y, Akuta N, Kobayashi M, Kawamura Y et al (2008) Hepatitic C virus enhances incidence of idiopathic pulmonary fibrosis. World J Gastroenterol 14(64):5880-5886
24. Sanghavi SK, Abu-Elmagd K, Keightley MC, St. George K, Lewandowksi K, Boes SS et al (2008) Relationship of cytomegalovirus load assessed by real-time PCR to pp 65 antigenemia in organ transplant recipients. J Clin Virol 42:335-342
25. De Paschale M, Agrappi C, Manco MT, Clerici P (2010) Positive predictive value of anti-HCV IgM as an index of primary infection. J Virol Methods 168:121-125
26. Bewig B, Haacke TC, Tiroke A, Bastian A, Böttcher H, Hirt SW et al (2000) Detection of CMV pneumonitis after lung transplantation using PCR of DNA from bronchoalveolar lavage cells. Respiration 67:166-172
27. Marzouk K, Corate L, Saleh S, Sharma OP (2005) Epstein-Barr-virus-induced interstitial lung disease. Curr Opin Pulm Med 11:456-460
28. De Paschale M, Agrappi C, Manco MT, Mirri P, Vigano EF, Clerici P (2009) Seroepidemiology of EBV and interpretation of the 'isolated VCA IgG' pattern. J Med Virol 81:325-331
29. Hess RD (2004) Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years. J Clin Microbiol 42(8):3381-3387
30. Popa V, Colby T, Reich SB (2002) Pulmonary interstitial disease in Ig deficiency. Chest 122:1594-1603
31. 4-related interstitial lung disease: a new and evolving concept. Curr Opin Pulm Med 15:513-516
32. Lanham JG, Elkon KB, Pusey CD, Hughes GR (1984) Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss Syndrome. Medicine 63(2):65-81
33. Latsi PI, du Bois RM, Nicholson AG, Colby TV, Bisirtzoglou D, Nikolakopoulou A et al (2003) Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 168:531-537
34. Eaton T, Young P, Milne D, Wells AU (2005) Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 171:1150-1157
35. King TE (2008) Interstitial lung diseases. In: Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL et al (eds) Harrison's principles of internal medicine, 17th edn. McGraw-Hill, New York, pp 1643-1651
36. Chetta A, Marangio E, Olivieri D (2004) Pulmonary function testing in interstitial lung diseases. Respiration 71:209-213
37. Salhi B, Troosters T, Behaegel M, Joos G, Derom E (2010) Effects of pulmonary rehabilitation in patients with restrictive lung diseases. Chest 137(2):273-279
38. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK et al (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788-824
39. Ohshimo S, Bonella F, Cui A, Beume M, Kohno N, Guzman J, Costabel U (2009) Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179:1043-1047
40. Flori P, Bellete B, Durand F, Raberin H, Cazorla C, Hafid J et al (2004) Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens. J Med Microbiol 53:603-607
41. Corey L (2008) Herpes simplex viruses. In: Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL et al (eds) Harrison's principles of internal medicine, 17th edn. McGraw-Hill, New York, pp 1095-1102
42. Scheithauer S, Manemann AK, Krüger S, Häusler M, Krüttgen A, Lemmen SW et al (2010) Impact of herpes simplex virus detection in respiratory specimens of patients with suspected viral pneumonia. Infection 38:401-405
43. Whitley RJ (2008) Varicella-zoster virus infections. In: Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL et al (eds) Harrison's principles of internal medicine, 17th edn. McGraw-Hill, New York, pp 1102-1105
44. Cowl CT, Prakash UB, Shawn Mitchell P, Migden MR (2000) Varicella-zoster virus detection by polymerase chain reaction using bronchoalveolar lavage specimens. Am J Respir Crit Care Med 161:753-754
45. Moxham J, Castello J (2002) Respiratory disease. In: Souhami RL, Moxham J (eds) Textbook of medicine, 4th edn. Churchill Livingstone, Philadelphia, pp 670-686
46. Raghu A (2012) IPF. Am J Respir Crit Care Med 185:A3632
47. King TE, Behr J, Brown KK, du Bois RM, Lancaster L, de Andrade JA et al (2008) BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 177(1):75-81
48. King TE, Brown KK, Raghu G, du Bois RM, Lynch DA, Martinez F et al (2011) BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 184(1):92-99
49. Raghu M (2012) Am J Respir Crit Care Med 185:A3631
50. Idiopathic Pulmonary Fibrosis Clinical Research Network, Zisman DA, Schwarz M, Anstrom KJ, Collard HR, Flaherty KR, Hunninghake GW (2010) A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med 363:620-628
51. Danoff SK, Terry PB, Horton MR (2007) A clinician's guide to the diagnosis and treatment of interstitial lung diseases. South Med J 100(6):579-587
52. Nicholson AG, Addis BJ, Bharucha H, Clelland CA, Corrin B, Gibbs AR et al (2004) Inter-observer variation between pathologists in diffuse parenchymal lung disease. Thorax 59:500-505